Connect with us

COVID-19

Canadian gov’t admits it gambled in deal with COVID vaccine maker that lost $150 million

Published

1 year ago

8 minute read

From LifeSiteNews

By Anthony Murdoch

A contract with Medicago Inc. called for 76 million doses of its own COVID shot to be made, but not one was ever delivered.

Canada’s Public Works department admitted that it took a massive gamble with taxpayer money that resulted in a loss of $150 million of taxpayer money after Quebec-based Medicago Inc.’s plan to build a COVID jab factory using federal funding failed to materialize.

On Monday, the Department of Public Works said it took a “risk” in subsidizing Medicago’s factory, which of note is in the Québec City riding of its own Minister Jean-Yves Duclos.

“We took a risk of putting contracts with various suppliers for enough vaccines for all Canadians,” admitted Joelle Paquette, who serves as the director general with the public works department while testifying before the House of Commons health committee on Monday.

Medicago’s failed contract called for 76 million doses of its own COVID jab to be made. However, not one was ever delivered. Medicago is a subsidiary of Japan-based Mitsubishi Chemical Group.

Last month, LifeSiteNews reported on how the House of Commons health committee has been demanding answers into how more than $300 million of taxpayer money was lost on failed COVID jab ventures with pharmaceutical companies.

It was recently revealed that the Public Health Agency of Canada (PHAC) lost $150 million on an unfulfilled COVID jab contract with an undisclosed entity in 2022. In addition, $173 million given to Medicago Inc., which said it would be shutting down in 2023 due to a failed development of its own plant-based COVID shot, is now lost.

Health Canada only approved mRNA-based COVID shots made in other countries, such as Pfizer’s and Moderna’s, as well as one from Johnson & Johnson.

In September, Health Canada approved a revised Moderna mRNA-based COVID shot despite research showing that 1 in 35 recipients of the booster ended up with myocardial damage.

In 2021, Duclos had gloated to the House of Commons that he had the “privilege of having Medicago in my riding.”

In reply, Paquette said, “Medicago owns the intellectual property.”

Perkins said that it is “just unbelievable” how the failed contract was allowed to proceed, with apparently no accountability.

Paquette admitted that the contact was not normal.

“We did not know at the time which vaccines would actually be authorized,” said Paquette, adding that there was “no vaccine that existed at the time we put these contracts in place. We took a risk.”

Andrea Andrachuk, another director general with the Department of Public Works, said that the $150 million was given to Medicago under a 2020 Advance Purchase Agreement. However, this contract was voided after Medicago announced last February that it was closing the plant.

Andrachuk noted how “Medicago was also facing product challenges and delivery date challenges” and that talks were underway to “revisit the contract.”

“The parent company Mitsubishi announced it was going to discontinue its activities in North America,” she said.

However, as part of the payment terms, a “150 million non-refundable advance payment” was made to Japan-based Medicago in “accordance with the Advance Purchase Agreement,” Andrachuk added.

“Medicago met all terms for the payment,” Andrachuk noted.

However, MPs were told that the terms of the Advance Purchase Agreement were secret. This prompted Bloc Québécois MP Julie Vignola to ask, “Could you tell us something about those conditions?”

In response, Andrachuk said, “No I cannot,” claiming that at the time there was “a lot of risk.”

“We didn’t know which vaccines if any would get Health Canada approval and even if they did, when they would be available,” Andrachuk claimed.

The government of Prime Minister Justin Trudeau spent some $8 billion on vaccines, with Pfizer alone getting a large chunk of that money. Health Canada ordered 238 million COVID injections from Pfizer Canada, which includes some 30 million for 2023 and 2024.

LifeSiteNews recently reported on how the details of the Canadian federal government’s COVID-19 vaccine contract with Pfizer for millions of doses of the mRNA-based experimental shots was recently disclosed after been hidden for over three years.

The contract with Pfizer shows the government agreed to accept the unknown long-term safety and efficacy of the shots. The details of the Pfizer contract do not disclose how much the government spent on the jabs.

The Trudeau government also signed COVID-19 contracts with AstraZeneca, Johnson & Johnson, Medicago, Moderna, Novavax, and Sanofi. According to industry rates, the average price of a shot when sold to the United States was $19.50.

Trudeau’s government pushed COVID jabs on people with help of provincial governments

The COVID shots were heavily promoted by the Trudeau government, with the help of all provincial governments. During the so-called COVID pandemic, Trudeau referred to those who chose not to get the experimental COVID shots as terrible people.

In 2021, Trudeau said Canadians “vehemently opposed to vaccination” do “not believe in science,” are “often misogynists, often racists,” and questioned whether Canada should continue to “tolerate these people.”

In April, he came under fire after claiming he did not “force” anyone to take the COVID-19 shots.

There is mounting evidence that mRNA-based COVID injections carry extreme risks, including for children.

A recent study done by researchers at the Canada-based Correlation Research in the Public Interest  found that 17 countries have a “definite causal link” between peaks in all-cause mortality and the fast rollouts of the COVID shots and boosters.

LifeSiteNews reported last month how the Polyomavirus Simian Virus 40 (SV40), which is a monkey-linked DNA sequence known to cause cancer when it was used in old polio vaccines, has been confirmed by Health Canada to be present in the Pfizer COVID shot, a fact that was not disclosed by the vaccine maker to officials.

Canada’s Conservative Party, although silent early on during the COVID crisis, later came out opposing COVID mandates.

A recent bill championed by party leader Pierre Poilievre that would have given Canadians back their “bodily autonomy” by banning future jab mandates was voted down after Trudeau’s Liberals and other parties rejected it.

Adverse effects from the first round of COVID shots have resulted in a growing number of Canadians filing for financial compensation over injuries from the jabs via the federal Vaccine Injury Program (VISP).

VISP has already paid over $6 million to those injured by COVID injections, with 2,000 claims remaining to be settled.

Related Topics:

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

More from this author
2025 Federal Election / 4 hours ago

The Liberals torched their own agenda just to cling to power

Business / 4 hours ago

Canada urgently needs a watchdog for government waste

Business / 6 hours ago

Trump says he expects ‘great relationship’ with Carney, who ‘hated’ him less than Poilievre

COVID-19

Study finds Pfizer COVID vaccine poses 37% greater mortality risk than Moderna

Published on May 1, 2025

By

From LifeSiteNews

By Nicolas Hulscher, MPH

A study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause mortality after Pfizer vaccination compared to Moderna

A new study of 1.47 million Florida adults by MIT’s Retsef Levi and Surgeon General Joseph Ladapo finds significantly higher all-cause, cardiovascular, and COVID-19 mortality after Pfizer vaccination.

The study titled “Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida” was just uploaded to the MedRxiv preprint server. This study was headed by MIT Professor Retsef Levi, with Florida Surgeon General Dr. Joseph Ladapo serving as senior author:

Study Overview

  • Population: 1,470,100 noninstitutionalized Florida adults (735,050 Pfizer recipients and 735,050 Moderna recipients).
  • Intervention: Two doses of either:
    • BNT162b2 (Pfizer-BioNTech)
    • mRNA-1273 (Moderna)
  • Follow-up Duration: 12 months after second dose.
  • Comparison: Head-to-head between Pfizer vs. Moderna recipients.
  • Main Outcomes:
    • All-cause mortality
    • Cardiovascular mortality
    • COVID-19 mortality
    • Non-COVID-19 mortality

All-cause mortality

Pfizer recipients had a significantly higher 12-month all-cause death rate than Moderna recipients — about 37% higher risk.

  • Pfizer Risk: 847.2 deaths per 100,000 people
  • Moderna Risk: 617.9 deaths per 100,000 people
  • Risk Difference:
    ➔ +229.2 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.37 (i.e., 37% higher mortality risk with Pfizer)
  • Odds Ratio (Adjusted):
    ➔ 1.384 (95% CI: 1.331–1.439)

Cardiovascular mortality

Pfizer recipients had a 53% higher risk of dying from cardiovascular causes compared to Moderna recipients.

  • Pfizer Risk: 248.7 deaths per 100,000 people
  • Moderna Risk: 162.4 deaths per 100,000 people
  • Risk Difference:
    ➔ +86.3 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.53 (i.e., 53% higher cardiovascular mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.540 (95% CI: 1.431–1.657)

COVID-19 mortality

Pfizer recipients had nearly double the risk of COVID-19 death compared to Moderna recipients.

  • Pfizer Risk: 55.5 deaths per 100,000 people
  • Moderna Risk: 29.5 deaths per 100,000 people
  • Risk Difference:
    ➔ +26.0 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.88 (i.e., 88% higher COVID-19 mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.882 (95% CI: 1.596–2.220)

Non-COVID-19 mortality

Pfizer recipients faced a 35% higher risk of dying from non-COVID causes compared to Moderna recipients.

  • Pfizer Risk: 791.6 deaths per 100,000 people
  • Moderna Risk: 588.4 deaths per 100,000 people
  • Risk Difference:
    ➔ +203.3 deaths per 100,000 (Pfizer excess)
  • Risk Ratio (RR):
    ➔ 1.35 (i.e., 35% higher non-COVID mortality risk)
  • Odds Ratio (Adjusted):
    ➔ 1.356 (95% CI: 1.303–1.412)

Biological explanations

The findings of this study are surprising, given that Moderna’s mRNA-1273 vaccine contains approximately three times more mRNA (100 µg) than Pfizer’s BNT162b2 vaccine (30 µg). This suggests that the higher mortality observed among Pfizer recipients could potentially be related to higher levels of DNA contamination — an issue that has been consistently reported worldwide:

The paper hypothesizes differences between Pfizer and Moderna may be due to:

  • Different lipid nanoparticle compositions
  • Differences in manufacturing, biodistribution, or storage conditions

Final conclusion

Florida adults who received Pfizer’s BNT162b2 vaccine had higher 12-month risks of all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to Moderna’s mRNA-1273 vaccine recipients.

Unfortunately, without an unvaccinated group, the study cannot determine the absolute increase in mortality risk attributable to mRNA vaccination itself. However, based on the mountain of existing evidence, it is likely that an unvaccinated cohort would have experienced much lower mortality risks. It’s also important to remember that Moderna mRNA injections are still dangerous.

As the authors conclude:

These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend beyond their targeted diseases.

Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

www.mcculloughfnd.org

Please consider following both the McCullough Foundation and my personal accounton X (formerly Twitter) for further content.

Reprinted with permission from Focal Points.

Continue Reading

COVID-19

Canada’s health department warns COVID vaccine injury payouts to exceed $75 million budget

Published on April 30, 2025

By

Fr0m LifeSiteNews

By Clare Marie Merkowsky

A Department of Health memo warns that Canada’s Vaccine Injury Support Program will exceed its $75 million budget due to high demand, with $16 million already paid out.

COVID vaccine injury payments are expected to go over budget, according to a Canadian Department of Health memo.

According to information published April 28 by Blacklock’s Reporter, the Department of Health will exceed their projected payouts for COVID vaccine injuries, despite already spending $16 million on compensating those harmed by the once-mandated experimental shots.

“A total $75 million in funding has been earmarked for the first five years of the program and $9 million on an ongoing basis,” the December memo read. “However the overall cost of the program is dependent on the volume of claims and compensation awarded over time, and that the demand remains at very high levels.”

“The purpose of this funding is to ensure people in Canada who experience a serious and permanent injury as a result of receiving a Health Canada authorized vaccine administered in Canada on or after December 8, 2020 have access to a fair and timely financial support mechanism,” it continued.

Canada’s Vaccine Injury Support Program (VISP) was launched in December 2020 after the Canadian government gave vaccine makers a shield from liability regarding COVID-19 jab-related injuries.

While Parliament originally budgeted $75 million, thousands of Canadians have filed claims after received the so-called “safe and effective” COVID shots. Of the 3,060 claims received to date, only 219 had been approved so far, with payouts totaling over $16 million.

Since the start of the COVID crisis, official data shows that the virus has been listed as the cause of death for less than 20 kids in Canada under age 15. This is out of six million children in the age group.

The COVID jabs approved in Canada have also been associated with severe side effects such as blood clots, rashes, miscarriages, and even heart attacks in young, healthy men.

Additionally, a recent study done by researchers with Canada-based Correlation Research in the Public Interest showed that 17 countries have found a “definite causal link” between peaks in all-cause mortality and the fast rollouts of the COVID shots as well as boosters.

Interestingly, while the Department of Health has spent $16 million on injury payouts, the Liberal government spent $54 million COVID propaganda promoting the vaccine to young Canadians.

The Public Health Agency of Canada especially targeted young Canadians ages 18-24 because they “may play down the seriousness of the situation.”

The campaign took place despite the fact that the Liberal government knew about COVID vaccine injuries, according to a secret memo.

Continue Reading

Trending

X